An antibody derived from a cured AML patient to identify a unique epitope on CD43 (CD43s) as a novel target for acute myeloid leukemia and myelodysplastic syndrome
Author(s):
Hazenberg, M.D.; Gillissen, M.; Jong, G. de; Yasuda, E.; Levie, S.; Wagner, K.; Bakker, A.; Kedde, M.; Hensbergen, P.; Villaudy, J.; Heiden, P. van; Spits, H.
